Unknowingly infected individuals may be spreading COVID as widely as those who’ve tested positive

CDC researchers are estimating that asymptomatic COVID-19 carriers account for at least half of all community transmissions. This includes carriers who never develop symptoms as well as those who later do.

Jay Butler, MD, the agency’s deputy director for infectious diseases, and colleagues used data from a meta-analysis of eight studies to calculate the proportion.

Their models took into account varying times from infection to times of elevated and peak contagiousness.

JAMA Network Open has posted the team’s report.

Butler and co-authors recommend strategic testing of evidently well people who work in or near crowded settings and those who know they were in close proximity to someone who turned out to have COVID.

“Multiple measures that effectively address transmission risk in the absence of symptoms are imperative to control SARS-CoV-2,” they write.

Full report here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.